Allotment

Influx Healthtech Limited launched a book-built IPO to raise ₹58.57 crore, comprising a fresh issue of 0.50 crore shares aggregating to ₹48.00 crore and an offer for sale of 0.11 crore shares aggregating to ₹10.56 crore. The IPO was open for bidding from June 18 to June 20, 2025, with allotment finalized on June 23, 2025. The shares were subsequently listed on the NSE SME platform on June 25, 2025.
The IPO price band was set at ₹96 per share, with a lot size of 1,200 shares per application. Retail investors were required to invest a minimum of ₹1,09,200 for one lot, while High Net Worth Investors (HNI) needed to apply for a minimum of 2 lots (2,400 shares), totaling ₹2,30,400.
Key Participants
Book Running Lead Manager: Rarever Financial Advisors Pvt. Ltd.
Registrar: Maashitla Securities Pvt. Ltd.
Market Maker: R.K. Stock Holding Pvt. Ltd.
The IPO provided investors an opportunity to participate in the growth of Influx Healthtech Limited, a company focused on advancing healthcare solutions and technologies to meet the evolving demands of the healthtech sector.
₹960%
Open
HIgh - Low
Previous Close
Total Traded Value
52 Weeks High
52 Weeks Low
Updates On
IPO. Open
IPO. Close
IPO. Price
IPO Market price
| IPO Date | 25 Jun |
| IPO Listing Date | 25 Jun |
| IPO Face Value | ₹10 per share |
| IPO Price Range | ₹96.00 |
| IPO Issue Size | 61,00,800 shares |
| IPO Sale Type | Fresh Capital & OFS |
| Employee Discount | - |
| IPO Issue Type | Bookbuilding IPO |
| IPO Listing | NSE SME Platform |
| Share Holding Pre Issue | 1,81,50,000 shares |
| IPO Open Date | 18 Jun |
| IPO Close Date | 20 Jun |
| IPO Allotment (Tentative) | 23 Jun |
| Refunds | 24 Jun |
| Credit to Demat Account | 24 Jun |
| IPO Listing Date | 25 Jun |
| Category | Offer |
|---|---|
| QIB Shares Offered | 28,95,600 Shares |
| NII (HNI) Shares Offered | 8,70,000 Shares |
| Retail Shares Offered | 20,29,200 Shares |
Investors can bid for a minimum of 1,200 shares, with additional bids in multiples of 1,200 shares.
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,15,200 |
| Retail (Max) | 1 | 1,200 | ₹1,15,200 |
| S-HNI (Min) | 2 | 2,400 | ₹2,30,400 |
| S-HNI (Max) | - | - | - |
| B-HNI (Min) | - | - | - |
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specializing in contract manufacturing. Operating as a trusted CDMO (Contract Development and Manufacturing Organization), the company provides specialized services to clients across multiple industries, enabling them to efficiently bring their products to market.
Manufacturing Facilities & Operations
The company has three state-of-the-art manufacturing facilities located in Thane, Maharashtra, covering areas of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. respectively. These facilities support a wide range of pharmaceutical, nutraceutical, cosmetic, and homecare products, ensuring high-quality production standards and regulatory compliance.
Product Portfolio
Influx Healthtech offers a diverse product range, including:
Pharmaceuticals: Tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules
Cosmetics & Personal Care: Skin care, body care, hair care, beard care solutions, face masks, soaps
Nutraceuticals & Supplements: Gym/sports supplements, Ayurvedic/herbal formulations, veterinary feed supplements
Homecare Solutions
The company supports nutraceutical and cosmetic firms with end-to-end services, including product development, manufacturing, and regulatory support, allowing clients to focus on formulation and commercialization.
Workforce & Competitive Strengths
As of June 11, 2025, Influx Healthtech employs 163 permanent employees. Its key competitive strengths include a diversified product portfolio, a broad and varied clientele, stringent quality assurance/quality control measures, and a team of experienced promoters and management professionals.
| Assets | 70.3 | 41.1 | 28.3 |
| Total Income | 104.99 | 100.1 | 76.07 |
| Profit After Tax | 13.37 | 11.22 | 7.2 |
| EBITDA | - | - | - |
| NET Worth | 36.15 | 22.87 | 11.65 |
| Reserves and Surplus | 18 | 22.85 | 11.63 |
| Total Borrowing | 0.22 | 0.32 | 0.8 |
| ROE | 36.98% |
| ROCE | 49.17% |
| Debt/Equity | 0.01 |
| RoNW | 36.98% |
| PAT Margin | 12.75% |
| EBITDA Margin | 19.62% |
| Price to Book Value | 4.82 |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | - |
| 2 | To meet out the expenses of Working Capital Requirement | - |
| 3 | To meet out the General Corporate Purposes; | 5.44 |
| 4 | Offer for Sale (OFS) | - |
Influx Healthtech Ltd. Address
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West,
Mumbai, Maharashtra, 400067
+91 7045997809
cs@influxhealthtech.com
https://influxhealthtech.com/
IPO Registrar
Maashitla Securities Pvt.Ltd.
+91-11-45121795-96
investor.ipo@maashitla.com
https://maashitla.com/allotment-status/public-issues